Search research articles
Contact Us
Filters
Showing results (31-40 of 37) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 37 results.
Circulation
|
January 1, 1990
An analysis of the cost effectiveness of the implantable defibrillator
M Kuppermann, B R Luce, B McGovern, et al.
Pharmacoeconomics
|
August 6, 1993
Cost analysis of imipenem-cilastatin versus clindamycin with tobramycin in the treatment of acute intra-abdominal infection
G de Lissovoy, A Elixhauser, B R Luce, et al.
Pharmacoeconomics
|
January 7, 1997
Guidelines for pharmacoeconomic studies. Recommendations from the panel on cost effectiveness in health and medicine. Panel on cost Effectiveness in Health and Medicine
J E Siegel, G W Torrance, L B Russell, et al.
Health Economics
|
November 14, 1997
Productivity costs, time costs and health-related quality of life: a response to the Erasmus Group
M C Weinstein, J E Siegel, A M Garber, et al.
Pharmacoeconomics
|
June 7, 1994
Recombinant human granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer: an economic analysis of a randomised, double-blind, placebo-controlled trial
B R Luce, J W Singer, J M Weschler, et al.
American Journal of Medical Quality : the Official Journal of the American College of Medical Quality
|
March 24, 1998
The economic and clinical efficiency of point-of-care testing for critically ill patients: a decision-analysis model
M T Halpern, C S Palmer, K N Simpson, et al.
Pediatrics
|
August 3, 2001
Cost-effectiveness analysis of an intranasal influenza vaccine for the prevention of influenza in healthy children
B R Luce, K M Zangwill, C S Palmer, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 37) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 37 results.
Circulation
|
January 1, 1990
An analysis of the cost effectiveness of the implantable defibrillator
M Kuppermann, B R Luce, B McGovern, et al.
Pharmacoeconomics
|
August 6, 1993
Cost analysis of imipenem-cilastatin versus clindamycin with tobramycin in the treatment of acute intra-abdominal infection
G de Lissovoy, A Elixhauser, B R Luce, et al.
Pharmacoeconomics
|
January 7, 1997
Guidelines for pharmacoeconomic studies. Recommendations from the panel on cost effectiveness in health and medicine. Panel on cost Effectiveness in Health and Medicine
J E Siegel, G W Torrance, L B Russell, et al.
Health Economics
|
November 14, 1997
Productivity costs, time costs and health-related quality of life: a response to the Erasmus Group
M C Weinstein, J E Siegel, A M Garber, et al.
Pharmacoeconomics
|
June 7, 1994
Recombinant human granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer: an economic analysis of a randomised, double-blind, placebo-controlled trial
B R Luce, J W Singer, J M Weschler, et al.
American Journal of Medical Quality : the Official Journal of the American College of Medical Quality
|
March 24, 1998
The economic and clinical efficiency of point-of-care testing for critically ill patients: a decision-analysis model
M T Halpern, C S Palmer, K N Simpson, et al.
Pediatrics
|
August 3, 2001
Cost-effectiveness analysis of an intranasal influenza vaccine for the prevention of influenza in healthy children
B R Luce, K M Zangwill, C S Palmer, et al.
Page
of 4